369
Pill imprint 369 has been identified as Metoprolol succinate ER 50 mg.
Metoprolol is used in the treatment of high blood pressure; heart failure; angina; supraventricular tachycardia; atrial fibrillation (and more), and belongs to the drug class cardioselective beta blockers. Risk cannot be ruled out during pregnancy.
Metoprolol 50 mg is not subject to the Controlled Substances Act.
See also related documents.
Metoprolol succinate ER Images
- Imprint:
-
369
- Strength:
- 50 mg
- Color:
- White
- Size:
- 10.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- calcium stearate
carboxymethylcellulose sodium
carnauba wax
croscarmellose sodium
glyceryl behenate
hypromellose
maltodextrin
methacrylic acid - methyl methacrylate copolymer (1:1)
microcrystalline cellulose
polydextrose
polyethylene glycol
povidone
sodium stearyl fumarate
titanium dioxide
triacetin
triethyl citrate
- Drug Class:
- Cardioselective beta blockers
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Ethex Corporation
- National Drug Code (NDC):
- 58177-0369
Advertisement
More Metoprolol Succinate ER resources
- Metoprolol
- Metoprolol Succinate Extended-Release Tablets (Wolters Kluwer)
- Metoprolol Tartrate (Wolters Kluwer)
- Metoprolol Tartrate Tablets (Wolters Kluwer)
- Metoprolol Tartrate (Cerner Multum)
- metoprolol (Cerner Multum)
- metoprolol (Micromedex) - Includes Dosage Information
- metoprolol Intravenous (Micromedex) - Includes Dosage Information
- Metoprolol Succinate (AHFS DI)
- Metoprolol Tartrate (AHFS DI)
- Metoprolol (FDA)
- Metoprolol Succinate (FDA)
- Metoprolol Tartrate Injection (FDA)
- Metoprolol (Wolters Kluwer)
Search Again
